Skip to main content

What the FDA labels say about taking them together

Epinephrine and phenoxybenzamine

Phenoxybenzamine's FDA label of July 3, 2026 names epinephrine in its drug interactions section; the epinephrine labels PlainMeds reads (4) do not name phenoxybenzamine.

Check it at the source: the epinephrine FDA label on DailyMed (effective July 13, 2026, A-S Medication Solutions); the phenoxybenzamine FDA label on DailyMed (effective July 3, 2026, Amneal Pharmaceuticals NY LLC).

What does the epinephrine label say about phenoxybenzamine?

Epinephrine's label (effective July 13, 2026) and its 3 other brand-application labels do not name phenoxybenzamine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Epinephrine), A-S Medication Solutions, effective July 13, 2026 (SPL set 6e811e28-0199-4df7-a916-5940c632401d), via openFDA; the full label on DailyMed

What does the phenoxybenzamine label say about epinephrine?

Phenoxybenzamine label, drug interactions

Drug Interactions 2 – Phenoxybenzamine hydrochloride may interact with compounds that stimulate both alpha- and beta- adrenergic receptors (i.e. epinephrine) to produce an exaggerated hypotensive response and tachycardia (see WARNING ).

Source: FDA drug label (Phenoxybenzamine hydrochloride), Amneal Pharmaceuticals NY LLC, effective July 3, 2026 (SPL set 0be6a394-cd10-42fc-97cf-ad53d81d8d93), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

16Epinephrine generic labelers
5Phenoxybenzamine generic labelers
EpinephrinePhenoxybenzamine
Labeled forAsthmaHigh blood pressure
Boxed warningNoNo
Pharmacy cost (NADAC)$123.51 per unit 0.15 mg auto-injctn/a
Shortage nowA presentation being discontinuedA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?